641
Participants
Start Date
March 1, 2022
Primary Completion Date
May 19, 2025
Study Completion Date
May 19, 2025
GSK3511294 (Depemokimab)
GSK3511294 (Depemokimab) will be administered using a pre-filled safety syringe.
GSK Investigational Site, Roma
GSK Investigational Site, Kaohsiung City
GSK Investigational Site, Gödöllő
GSK Investigational Site, Coffs Harbour
GSK Investigational Site, South Brisbane
GSK Investigational Site, Szigetvár
GSK Investigational Site, Mosonmagyaróvár
GSK Investigational Site, Hohhot
GSK Investigational Site, Berlin
GSK Investigational Site, The Bronx
GSK Investigational Site, Marseille
GSK Investigational Site, Caen
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, DuBois
GSK Investigational Site, Girona
GSK Investigational Site, Hershey
GSK Investigational Site, Granada
GSK Investigational Site, Rozzano MI
GSK Investigational Site, Milan
GSK Investigational Site, Hamburg
GSK Investigational Site, Taipei
GSK Investigational Site, Brescia
GSK Investigational Site, Pavia
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Madrid
GSK Investigational Site, Gastonia
GSK Investigational Site, Huntersville
GSK Investigational Site, Pozuelo de AlarcOn Madr
GSK Investigational Site, Benalmádena
GSK Investigational Site, Savannah
GSK Investigational Site, Orlando
GSK Investigational Site, Hialeah
GSK Investigational Site, Miami Lakes
GSK Investigational Site, Miami
GSK Investigational Site, Coral Gables
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Loxahatchee Groves
GSK Investigational Site, Gulfport
GSK Investigational Site, Strakonice
GSK Investigational Site, Santander
GSK Investigational Site, Magdeburg
GSK Investigational Site, Taichung
GSK Investigational Site, Lexington
GSK Investigational Site, Taichung
GSK Investigational Site, Cincinnati
GSK Investigational Site, Cincinnati
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Bilbao
GSK Investigational Site, Ypsilanti
GSK Investigational Site, Cholet
GSK Investigational Site, Zaragoza
GSK Investigational Site, Siena
GSK Investigational Site, Mainz
GSK Investigational Site, Koblenz
GSK Investigational Site, Frankfurt
GSK Investigational Site, Normal
GSK Investigational Site, Neu-Isenburg
GSK Investigational Site, Strasbourg
GSK Investigational Site, Foggia
GSK Investigational Site, Annecy
GSK Investigational Site, Allen
GSK Investigational Site, Dallas
GSK Investigational Site, Boerne
GSK Investigational Site, Kerrville
GSK Investigational Site, San Antonio
GSK Investigational Site, San Antonio
GSK Investigational Site, Lafayette
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Palermo
GSK Investigational Site, Lancaster
GSK Investigational Site, Messina
GSK Investigational Site, Bellingham
GSK Investigational Site, Shenyang
GSK Investigational Site, Shenyang
GSK Investigational Site, Changchun
GSK Investigational Site, Changchun
GSK Investigational Site, Shanghai
GSK Investigational Site, Shanghai
GSK Investigational Site, Xuzhou
GSK Investigational Site, Hefei
GSK Investigational Site, Jinan
GSK Investigational Site, Hangzhou
GSK Investigational Site, Wenzhou
GSK Investigational Site, Changsha
GSK Investigational Site, Wuhan
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Haikou
GSK Investigational Site, Chengdu
GSK Investigational Site, Ürümqi
GSK Investigational Site, Northfield
GSK Investigational Site, Sherwood Park
GSK Investigational Site, Kamloops
GSK Investigational Site, Ajax
GSK Investigational Site, Ottawa
GSK Investigational Site, Windsor
GSK Investigational Site, Brno
GSK Investigational Site, Hradec Králové
GSK Investigational Site, Jindřichův Hradec
GSK Investigational Site, Olomouc
GSK Investigational Site, Tábor
GSK Investigational Site, Teplice
GSK Investigational Site, Leipzig
GSK Investigational Site, Leipzig
GSK Investigational Site, Monserrato CA
GSK Investigational Site, Aichi
GSK Investigational Site, Aichi
GSK Investigational Site, Chiba
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukushima
GSK Investigational Site, Hiroshima
GSK Investigational Site, Hokkaido
GSK Investigational Site, Hokkaido
GSK Investigational Site, Kagawa
GSK Investigational Site, Kagawa
GSK Investigational Site, Kagoshima
GSK Investigational Site, Kanagawa
GSK Investigational Site, Kanagawa
GSK Investigational Site, Niigata
GSK Investigational Site, Okayama
GSK Investigational Site, Saga
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Gdansk
GSK Investigational Site, Kielce
GSK Investigational Site, Krakow
GSK Investigational Site, Krakow
GSK Investigational Site, Lodz
GSK Investigational Site, Lublin
GSK Investigational Site, Ostrowiec Świętokrzyski
GSK Investigational Site, Rzeszów
GSK Investigational Site, Strzelce Opolskie
GSK Investigational Site, Wroclaw
GSK Investigational Site, Barcelona
GSK Investigational Site, Madrid
GSK Investigational Site, Palma de Mallorca
GSK Investigational Site, Bradford
GSK Investigational Site, Chertsey
GSK Investigational Site, London
GSK Investigational Site, Manchester
GSK Investigational Site, Nottingham
Lead Sponsor
Iqvia Pty Ltd
INDUSTRY
GlaxoSmithKline
INDUSTRY